Simcha: Sequoia China backs $25m Series A round in US biotech firm Simcha
Other investors in the round included WuXi AppTec's corporate venture fund and Connecticut Innovations.
Read full article »
Simcha is a Connecticut-based clinical-stage biotechnology company that develops and commercializes engineered cytokine therapeutics for the treatment of cancer.
Read more